Women's Health

For more than a decade, the Feminist Majority Foundation has been encouraging and advocating for clinical trials using mifepristone, anti-progesterone compound medication formerly known as RU 486 (the abortion pill), for progesterone-receptor positive cancers primarily affecting women. Now, the Feminist Majority Foundation has put together a team of prestigious clinical researchers, attorneys, and FDA specialists, and is moving ahead with Phase II clinical trials for women with progesterone-dependent uterine and ovarian cancers. This type of cancer accounts for 60 percent of breast cancers, 85 percent of uterine cancers and 40 percent of ovarian cancers. Your help is crucial in moving the ground-breaking research forward. We need you to make as large a contribution as you possibly can afford. We want you to participate. When all else fails, feminists will and can make women's health research move forward. Move Women's Cancer Research Forward FMF's Mifepristone Compassionate Use Program Breast Cancer Resources Reproductive Rights Women's Health News 7/2/2009 HHS Proposes Regulations to Eliminate HIV Travel Ban GO>> 6/30/2009 American Medical Association Report Finds Abstinence-Only Sex Ed Ineffective GO>> 6/29/2009 HIV-Positive Namibian Women Suing Government for Forced Sterilization GO>> 6/29/2009 Indian Women's Studies Pioneer Dies GO>> 5/14/2009 Lawsuit Filed on Patents of Genes Associated with Breast Cancer GO>>       October is Breast Cancer Awareness Month Learn more at the Breast Cancer Information Center, and look for articles in the Fall 2005 issue of Ms. Magazine.